Leslie Harris O'Hanlon. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » AnimalsAntineoplastic Agents/economicsAntineoplastic Agents/pharmacologyAntineoplastic Agents, Alkylating/pharmacologyClinical Trials as TopicDepsipeptides/pharmacologyDioxoles/pharmacologyEthers, Cyclic/isolation & purificationFurans/pharmacologyHumansIsoquinolines/pharmacologyKetones/pharmacologyMacrolidesNational Institutes of Health (U.S.)Oceans and SeasPeptides, Cyclic/biosynthesisPeptides, Cyclic/geneticsSeawaterTetrahydroisoquinolinesTrabectedinUnited States
Substances： See more » Antineoplastic AgentsAntineoplastic Agents, AlkylatingDepsipeptidesDioxolesEthers, CyclicFuransIsoquinolinesKetonesMacrolidesPeptides, CyclicTetrahydroisoquinolineshalichondrin Bpatellamide ATrabectedineribulinplitidepsin
Year: 2006 PMID： 16705115 DOI： 10.1093/jnci/djj218
Source DB: PubMed Journal: J Natl Cancer Inst ISSN： 0027-8874 Impact factor: 13.506